Wisconsin Rx National CooperativeRx
The SCRxIPT - Weekly Newsletter For Members and Stakeholders

Rx News | April 20, 2012

About Us
The Co-op Difference
Members
Employers
Brokers and TPAs
Cost Savings
Adding Value
Press Room
Event Calendar
How To Join Rx

Upcoming Events featuring
National CooperativeRx
WI- National CooperativeRx Annual Member Meeting
April 25, 2012
Madison, WI

CUPA-HR Midwest Regional Conference

May 6-8, 2012   

Milwaukee, WI
Learn more

Mid-Sized Retirement & Healthcare Plan Management Conference

June 5-8, 2012   

Chicago, IL 

Learn more
National CooperativeRx is a not-for-profit coalition founded and owned by plan sponsors to achieve higher value prescription benefits through volume purchasing, clinical solutions, actionable data and unparalleled customer service. For your sales and marketing needs, please contact us at 866-679-9479, extension 223

Coalition News
Annual Member Meeting April 25

We here at National CooperativeRx | WisconsinRx are looking forward to hosting our Annual Member Meeting in Madison, WI next Wednesday, April 25.  If you have any questions regarding directions or event details, please don't hesitate to call us at 608-204-9479.

National Take Back Day April 28

If you or your employees have any expired or unused medications to dispose of, Saturday, April 28 is a great day to do it.  There are many communities participating in the Take Back event.  To see if there is a drop-off site near you, click here.

 

Getting rid of your unused medication in an appropriate manner will help to keep our waters clean while also preventing drugs from falling into the hands of people who may abuse them.   

 

National Infant Immunization Week April 21-28

 

Next week is National Infant Immunization Week (NIIW).  NIIW is an annual observance to highlight the importance of protecting infants from vaccine-preventable diseases and celebrate the achievements of immunization programs.  For further detail, click here

 

 

News You Can Use
Huffington Post.  Statins have been on the market for over two decades, and one in four Americans are now taking one.  Now that more reports have emerged, the FDA is revising the label to include updated warnings such as memory loss and increased blood sugar levels.  (Braunstein, 4/16Full story

The Wall Street Journal.  Some patients suffering from ALS (or Lou Gehrig's disease) have began to experiment with brewing their own medications.  Frustrated with the slow pace of clinical trials and suffering from a fatal disease, many figure they can't wait for drugs to be approved.  Click into the link to read about how they're taking matters into their own hands.  (Marcus, 4/15)  Full story  

 

Industry News

The Atlantic.  The FDA's voluntary guidelines on how antibiotics should and shouldn't be used in farm animals meant for human consumption are being blamed for not going far enough to protect public health.  This article goes further in depth on the issue.  (Lawrence, 4/16Full story  

 

The Wall Street Journal.  People using Medicare Part D who fell into the 'donut hole' were 57% less likely to continue cardiovascular medications than those with consistent drug coverage.  The study, performed by Brigham and Women's Hospital Research and CVS Caremark, was published in the journal Circulation.  (4/17)  Full story  

 

Health Policy Matters

Time.  The FDA held a hearing last week to consider making naloxone available as an over-the-counter drug.  Naloxone is a non-addictive, non-toxic, lifesaving drug that is administered to people who have an opioid overdose.  Many parents were there to testify in favor of the drug, stating that it could have saved their child's life.  (Szalavitz, 4/13)  Full story  

 

The Washington Post. The Supreme Court has heard the case against the pharmaceutical industry's practice of not paying overtime to its sales representatives.  Companies with sales staff aren't required to pay overtime, but the representatives in the case are stating that because they can't close a deal with doctors, they aren't technically in a sales position and should receive overtime.  There are approximately 90,000 sales representatives in the pharmaceutical industry.  A decision is expected in June.  (4/16)  Full story